DENTSPLY SIRONA (NASDAQ:XRAY) Stock Rating Lowered by Leerink Partners

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by research analysts at Leerink Partners from an “outperform” rating to a “market perform” rating in a report issued on Thursday, MarketBeat reports.

A number of other research firms have also weighed in on XRAY. Evercore ISI dropped their target price on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Needham & Company LLC dropped their price objective on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Wednesday. Stifel Nicolaus dropped their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research report on Thursday, July 18th. Finally, Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a report on Monday, July 22nd. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $31.88.

DENTSPLY SIRONA Stock Down 20.6 %

NASDAQ XRAY traded down $4.95 during trading hours on Thursday, hitting $19.03. The company’s stock had a trading volume of 6,521,394 shares, compared to its average volume of 2,974,800. The company has a market capitalization of $3.86 billion, a PE ratio of -22.27, a price-to-earnings-growth ratio of 1.27 and a beta of 1.02. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. DENTSPLY SIRONA has a 52 week low of $18.95 and a 52 week high of $37.60. The company’s 50-day simple moving average is $24.99 and its two-hundred day simple moving average is $26.04.

Institutional Trading of DENTSPLY SIRONA

Several hedge funds have recently added to or reduced their stakes in XRAY. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of DENTSPLY SIRONA by 44.2% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 141,117 shares of the medical instruments supplier’s stock worth $4,684,000 after purchasing an additional 43,230 shares during the period. Scientech Research LLC purchased a new position in shares of DENTSPLY SIRONA during the 2nd quarter valued at $846,000. Seven Eight Capital LP purchased a new stake in DENTSPLY SIRONA in the 1st quarter worth about $1,409,000. Illinois Municipal Retirement Fund raised its stake in DENTSPLY SIRONA by 369.9% in the 1st quarter. Illinois Municipal Retirement Fund now owns 123,580 shares of the medical instruments supplier’s stock valued at $4,102,000 after acquiring an additional 97,281 shares during the period. Finally, Intech Investment Management LLC purchased a new stake in DENTSPLY SIRONA during the first quarter valued at about $1,202,000. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.